AMLX
Price
$14.87
Change
+$0.92 (+6.59%)
Updated
Nov 19, 01:31 PM (EDT)
Capitalization
1.54B
133 days until earnings call
Intraday BUY SELL Signals
ATYR
Price
$0.68
Change
-$0.02 (-2.86%)
Updated
Nov 19, 04:21 PM (EDT)
Capitalization
69.32M
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs ATYR

Header iconAMLX vs ATYR Comparison
Open Charts AMLX vs ATYRBanner chart's image
Amylyx Pharmaceuticals
Price$14.87
Change+$0.92 (+6.59%)
Volume$7.08K
Capitalization1.54B
aTyr Pharma
Price$0.68
Change-$0.02 (-2.86%)
Volume$3.55K
Capitalization69.32M
AMLX vs ATYR Comparison Chart in %
AMLX
Daily Signal:
Gain/Loss:
ATYR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMLX vs. ATYR commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and ATYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (AMLX: $13.95 vs. ATYR: $0.71)
Brand notoriety: AMLX and ATYR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 73% vs. ATYR: 32%
Market capitalization -- AMLX: $1.54B vs. ATYR: $69.32M
AMLX [@Biotechnology] is valued at $1.54B. ATYR’s [@Biotechnology] market capitalization is $69.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileATYR’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ATYR’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 6 TA indicator(s) are bullish while ATYR’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 6 bullish, 4 bearish.
  • ATYR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than ATYR.

Price Growth

AMLX (@Biotechnology) experienced а +10.02% price change this week, while ATYR (@Biotechnology) price change was -10.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.73%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

ATYR is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.54B) has a higher market cap than ATYR($69.3M). AMLX YTD gains are higher at: 269.048 vs. ATYR (-80.457). ATYR has higher annual earnings (EBITDA): -68.89M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. ATYR (80.3M). AMLX has less debt than ATYR: AMLX (5.96M) vs ATYR (12.7M). ATYR has higher revenues than AMLX: ATYR (0) vs AMLX (-249K).
AMLXATYRAMLX / ATYR
Capitalization1.54B69.3M2,216%
EBITDA-196.3M-68.89M285%
Gain YTD269.048-80.457-334%
P/E Ratio2.69N/A-
Revenue-249K0-
Total Cash181M80.3M225%
Total Debt5.96M12.7M47%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXATYR
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
ATYR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NZSTF0.87N/A
N/A
NZX Ltd
TGMR0.06N/A
N/A
Troy Gold & Mineral Corp.
BVHMY8.10N/A
N/A
VISTRY GROUP PLC.
ALSMY2.54-0.06
-2.40%
Alstom
AVLNF0.04N/A
-3.80%
Avalon Advanced Materials Inc.

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-0.21%
XOMAO - AMLX
68%
Closely correlated
+0.08%
XOMAP - AMLX
51%
Loosely correlated
N/A
OCUL - AMLX
50%
Loosely correlated
-1.09%
IPSC - AMLX
44%
Loosely correlated
+1.99%
SYRE - AMLX
44%
Loosely correlated
-1.07%
More